ZURICH (Reuters) - Swiss drugmaker Novartis AG on Tuesday stuck to its outlook for lower profitability this year, as a stoppage at a U.S. manufacturing site and tough comparisons in its Sandoz division hit first-quarter core earnings.
br />
Core earnings per share fell 10 percent to $1.27 in the first quarter, compared to the average estimate of $1.32 in a Reuters poll of analysts.